Avtar S Dhillon's Net Worth
$36.1 Million
Who is Avtar S Dhillon?
Avtar S Dhillon has an estimated net worth of $36.1 Million. This is based on reported shares across multiple companies, which include Arch Therapeutics, Inc., GENETRONICS BIOMEDICAL CORP, Nemus Bioscience, Inc., Stevia First Corp., and ONCOSEC MEDICAL Inc.
SEC CIK
Avtar S Dhillon's CIK is 0001260933
Past Insider Trading and Trends
2016 was Avtar S Dhillon's most active year for acquiring shares with 10 total transactions. Avtar S Dhillon's most active month to acquire stocks was the month of April. 2018 was Avtar S Dhillon's most active year for disposing of shares, totalling 14 transactions. Avtar S Dhillon's most active month to dispose stocks was the month of January. 2015 saw Avtar S Dhillon paying a total of $3,031,165.00 for 1,567,500 shares, this is the most they've acquired in one year. In 2018 Avtar S Dhillon cashed out on 170,244 shares for a total of $52,367.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arch Therapeutics, Inc. (ARTH) Snapshot price: $4.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
| +2.65% | 220K |
—
|
—
| 8.52M |
Jul 19
| |||
Form 4
| +5.06% | 400K |
—
|
—
| 8.3M |
Feb 3
| |||
Form 4
| +10.29% | 737K |
—
|
—
| 7.9M |
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| +2.29% | 160.37K |
—
|
—
| 7.16M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INOVIO PHARMACEUTICALS, INC. (INO) Snapshot price: $6.15
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.86% | 25K |
$2.00 | $50,000.00 | 106K |
Dec 6
| |||
Form 4
| +10.46% | 7.67K |
—
|
—
| 81K |
May 11 - May 12
| |||
Form 4
| +15.79% | 10K |
—
|
—
| 73.33K |
May 12 - May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
| +8.57% | 5K |
—
|
—
| 63.33K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
| +9.38% | 20K |
$0.72 | $14,400.00 | 233.33K |
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
| +55.47% | 75K |
—
|
—
| 210.21K |
Feb 1
| |||
Form 4
| +124.57% | 75K |
—
|
—
| 135.21K |
May 4
| |||
Form 4
| -55.47% | -75.00K |
—
|
—
| 60.21K |
Mar 30
| |||
Form 4/A
| +124.57% | 75K |
—
|
—
| 135.21K |
Mar 8
| |||
Form 4
| +124.57% | 75K |
—
|
—
| 135.21K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| +19.93% | 10K |
$2.52 | $25,236.00 | 60.19K |
Oct 14
| |||
Form 4
|
∞
| 2 |
$5,882.36 | $11,764.71 | 2 |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
No matching records found |
Nemus Bioscience, Inc. (SKYE) Snapshot price: $5.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vitality Biopharma, Inc. (MLCT) Snapshot price: $0.195
President,CEO,CFO,Sec and Tres
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +1,028.43% | 925.59K |
—
|
—
| 1.02M |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21 - Jul 15
| |||
Form 4
| -83.65% | -26.35M |
—
| -$57,970.00 | 5.15M |
Feb 3 - Feb 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ONCOSEC MEDICAL Inc (ONCSQ) Snapshot price: $0.111
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.23% | 12.5K |
$1.55 | $19,375.00 | 62.05K |
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +77.07% | 62.42K |
$1.39 | -$52,367.21 | 143.43K |
Jun 15 - Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
∞
| 10K |
$4.36 | $43,590.00 | 10K |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
∞
| 9.91M |
—
| $2,973.14 | 9.91M |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |